ラパチニブの世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE3830)
◆英語タイトル:Global Lapatinib Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE3830
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月
◆ページ数:85
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥546,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥819,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,092,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、ラパチニブの世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(250mg錠、タイプII)、用途別市場規模(病院、ドラッグストア)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・ラパチニブの市場動向
・企業の競争状況、市場シェア
・ラパチニブの種類別市場規模(250mg錠、タイプII)
・ラパチニブの用途別市場規模(病院、ドラッグストア)
・ラパチニブの北米市場規模2016-2027(アメリカ、カナダ)
・ラパチニブの欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・ラパチニブのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・ラパチニブの中南米市場規模2016-2027(メキシコ、ブラジル)
・ラパチニブの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Novartis)
・結論
【レポートの概要】

Lapatinib (INN), used in the form of lapatinib ditosylate (USAN) (trade names Tykerb and Tyverb) is an orally active drug for breast cancer and other solid tumours.

Market Analysis and Insights: Global Lapatinib Market
The global Lapatinib market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lapatinib market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lapatinib market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lapatinib market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lapatinib market.

Global Lapatinib Scope and Market Size
Lapatinib market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lapatinib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
250 mg Tablets
Type II

Segment by Application
Hospital
Drug store

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lapatinib Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 250 mg Tablets
1.2.3 Type II
1.3 Market by Application
1.3.1 Global Lapatinib Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lapatinib Market Perspective (2016-2027)
2.2 Lapatinib Growth Trends by Regions
2.2.1 Lapatinib Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lapatinib Historic Market Share by Regions (2016-2021)
2.2.3 Lapatinib Forecasted Market Size by Regions (2022-2027)
2.3 Lapatinib Industry Dynamic
2.3.1 Lapatinib Market Trends
2.3.2 Lapatinib Market Drivers
2.3.3 Lapatinib Market Challenges
2.3.4 Lapatinib Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lapatinib Players by Revenue
3.1.1 Global Top Lapatinib Players by Revenue (2016-2021)
3.1.2 Global Lapatinib Revenue Market Share by Players (2016-2021)
3.2 Global Lapatinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lapatinib Revenue
3.4 Global Lapatinib Market Concentration Ratio
3.4.1 Global Lapatinib Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lapatinib Revenue in 2020
3.5 Lapatinib Key Players Head office and Area Served
3.6 Key Players Lapatinib Product Solution and Service
3.7 Date of Enter into Lapatinib Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lapatinib Breakdown Data by Type
4.1 Global Lapatinib Historic Market Size by Type (2016-2021)
4.2 Global Lapatinib Forecasted Market Size by Type (2022-2027)

5 Lapatinib Breakdown Data by Application
5.1 Global Lapatinib Historic Market Size by Application (2016-2021)
5.2 Global Lapatinib Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lapatinib Market Size (2016-2027)
6.2 North America Lapatinib Market Size by Type
6.2.1 North America Lapatinib Market Size by Type (2016-2021)
6.2.2 North America Lapatinib Market Size by Type (2022-2027)
6.2.3 North America Lapatinib Market Size by Type (2016-2027)
6.3 North America Lapatinib Market Size by Application
6.3.1 North America Lapatinib Market Size by Application (2016-2021)
6.3.2 North America Lapatinib Market Size by Application (2022-2027)
6.3.3 North America Lapatinib Market Size by Application (2016-2027)
6.4 North America Lapatinib Market Size by Country
6.4.1 North America Lapatinib Market Size by Country (2016-2021)
6.4.2 North America Lapatinib Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Lapatinib Market Size (2016-2027)
7.2 Europe Lapatinib Market Size by Type
7.2.1 Europe Lapatinib Market Size by Type (2016-2021)
7.2.2 Europe Lapatinib Market Size by Type (2022-2027)
7.2.3 Europe Lapatinib Market Size by Type (2016-2027)
7.3 Europe Lapatinib Market Size by Application
7.3.1 Europe Lapatinib Market Size by Application (2016-2021)
7.3.2 Europe Lapatinib Market Size by Application (2022-2027)
7.3.3 Europe Lapatinib Market Size by Application (2016-2027)
7.4 Europe Lapatinib Market Size by Country
7.4.1 Europe Lapatinib Market Size by Country (2016-2021)
7.4.2 Europe Lapatinib Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lapatinib Market Size (2016-2027)
8.2 Asia-Pacific Lapatinib Market Size by Type
8.2.1 Asia-Pacific Lapatinib Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lapatinib Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lapatinib Market Size by Type (2016-2027)
8.3 Asia-Pacific Lapatinib Market Size by Application
8.3.1 Asia-Pacific Lapatinib Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lapatinib Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lapatinib Market Size by Application (2016-2027)
8.4 Asia-Pacific Lapatinib Market Size by Region
8.4.1 Asia-Pacific Lapatinib Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lapatinib Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lapatinib Market Size (2016-2027)
9.2 Latin America Lapatinib Market Size by Type
9.2.1 Latin America Lapatinib Market Size by Type (2016-2021)
9.2.2 Latin America Lapatinib Market Size by Type (2022-2027)
9.2.3 Latin America Lapatinib Market Size by Type (2016-2027)
9.3 Latin America Lapatinib Market Size by Application
9.3.1 Latin America Lapatinib Market Size by Application (2016-2021)
9.3.2 Latin America Lapatinib Market Size by Application (2022-2027)
9.3.3 Latin America Lapatinib Market Size by Application (2016-2027)
9.4 Latin America Lapatinib Market Size by Country
9.4.1 Latin America Lapatinib Market Size by Country (2016-2021)
9.4.2 Latin America Lapatinib Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lapatinib Market Size (2016-2027)
10.2 Middle East & Africa Lapatinib Market Size by Type
10.2.1 Middle East & Africa Lapatinib Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lapatinib Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lapatinib Market Size by Type (2016-2027)
10.3 Middle East & Africa Lapatinib Market Size by Application
10.3.1 Middle East & Africa Lapatinib Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lapatinib Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lapatinib Market Size by Application (2016-2027)
10.4 Middle East & Africa Lapatinib Market Size by Country
10.4.1 Middle East & Africa Lapatinib Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lapatinib Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Lapatinib Introduction
11.1.4 Novartis Revenue in Lapatinib Business (2016-2021)
11.1.5 Novartis Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ ラパチニブの世界市場規模・現状・予測2021年-2027年(Global Lapatinib Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。